NeuroPET's capabilities enable ultra high-sensitivity molecular imaging of the brain with minimal exposure to the subject or the technologist. The scanner uses low doses of 18F and 11C radiotracers to generate detailed images of the human brain. These radiotracers are known to be helpful in imaging metabolism, amyloid, and dopaminergic binding in neurological diseases such as Alzheimer’s, Parkinson’s, neuro-oncology, and neuropsychiatric disorders.  The NeuroPET components are compact (the largest fits through a 36-inch door) and can be moved from room-to-room. No special power supply or site preparation is necessary. Because the proprietary PDS technology achieves high imaging sensitivity with very low doses of radioactive tracers, subjects can be scanned over a series of successive visits for research or to track the progress of treatment.